Steripath Micro Commercialization & Evidence Generation

About Magnolia Medical Technologies

Magnolia Medical Technologies is a private commercial-stage company addressing a critical problem in hospital diagnostics: false-positive blood cultures due to contamination during sample collection. The company's FDA-cleared Steripath device physically diverts and sequesters the initial aliquot of blood, which is most likely to contain skin contaminants, thereby dramatically improving test accuracy. This innovation supports antimicrobial stewardship by reducing unnecessary antibiotic use, associated patient harm, and significant wasted healthcare resources. The company is led by an experienced team and is backed by clinical evidence and a growing body of peer-reviewed literature.

Therapeutic Areas

Other Prevention of Blood Culture Contamination Drugs